| ABBV |
AbbVie Inc. |
341.80B |
7.49% |
|
|
|
|
|
193.51 |
0.29% |
26.55% |
60.70% |
|---|
| PFE |
Pfizer Inc. |
169.04B |
7.34% |
|
|
|
|
|
29.83 |
0.27% |
27.87% |
32.32% |
|---|
| JNJ |
Johnson & Johnson |
396.57B |
6.99% |
|
|
|
|
|
164.74 |
-0.85% |
20.29% |
48.89% |
|---|
| BMY |
Bristol-Myers Squibb Company |
99.88B |
6.71% |
|
|
|
|
|
49.27 |
-0.95% |
31.12% |
70.51% |
|---|
| MRK |
Merck & Co., Inc. |
296.46B |
6.38% |
|
|
|
|
|
116.96 |
-1.42% |
21.19% |
30.70% |
|---|
| UTHR |
United Therapeutics Corporation |
15.64B |
4.80% |
|
|
|
|
|
351.58 |
2.62% |
25.77% |
37.27% |
|---|
| LLY |
Eli Lilly and Company |
865.99B |
4.14% |
|
|
|
|
|
911.16 |
0.68% |
32.30% |
17.67% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
125.71B |
4.07% |
|
|
|
|
|
1,159.53 |
1.82% |
25.78% |
44.23% |
|---|
| AMGN |
Amgen Inc. |
181.02B |
4.05% |
|
|
|
|
|
336.90 |
1.19% |
26.21% |
30.95% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
123.96B |
3.80% |
|
|
|
|
|
480.29 |
1.29% |
25.67% |
48.32% |
|---|
| GILD |
Gilead Sciences, Inc. |
105.08B |
3.73% |
|
|
|
|
|
84.40 |
0.61% |
22.75% |
21.24% |
|---|
| CAH |
Cardinal Health, Inc. |
27.02B |
3.41% |
|
|
|
|
|
110.81 |
-0.54% |
23.67% |
28.83% |
|---|
| VTRS |
Viatris Inc. |
14.42B |
3.22% |
|
|
|
|
|
12.09 |
1.55% |
30.86% |
40.63% |
|---|
| ZTS |
Zoetis Inc. |
88.00B |
3.22% |
|
|
|
|
|
194.24 |
-1.14% |
22.50% |
13.33% |
|---|
| BIIB |
Biogen Inc. |
29.51B |
3.18% |
|
|
|
|
|
202.60 |
2.53% |
27.31% |
24.65% |
|---|
| OGN |
Organon & Co. |
5.17B |
2.88% |
|
|
|
|
|
20.08 |
0.53% |
42.57% |
35.88% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
6.96B |
2.73% |
|
|
|
|
|
112.68 |
2.84% |
35.16% |
17.67% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.60B |
1.80% |
|
|
|
|
|
59.99 |
-3.72% |
35.56% |
27.82% |
|---|
| CRL |
Charles River Laboratories International... |
10.97B |
1.53% |
|
|
|
|
|
212.40 |
3.06% |
35.18% |
52.27% |
|---|
| PRGO |
Perrigo Company plc |
3.77B |
1.23% |
|
|
|
|
|
27.66 |
-1.77% |
44.03% |
45.50% |
|---|
| MEDP |
Medpace Holdings, Inc. |
11.59B |
1.19% |
|
|
|
|
|
373.77 |
3.45% |
38.72% |
42.79% |
|---|
| INCY |
Incyte Corporation |
12.74B |
1.03% |
|
|
|
|
|
66.14 |
1.49% |
21.51% |
37.71% |
|---|
| ALKS |
Alkermes plc |
4.66B |
0.96% |
|
|
|
|
|
28.30 |
1.69% |
37.86% |
56.93% |
|---|
| EXEL |
Exelixis, Inc. |
7.67B |
0.95% |
|
|
|
|
|
26.88 |
0.21% |
45.82% |
35.70% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
3.65B |
0.81% |
|
|
|
|
|
73.65 |
0.16% |
59.52% |
76.61% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
7.48B |
0.73% |
|
|
|
|
|
15.13 |
3.28% |
51.18% |
44.68% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
12.35B |
0.72% |
|
|
|
|
|
122.29 |
2.04% |
29.90% |
13.36% |
|---|
| ACLX |
Arcellx, Inc. |
4.52B |
0.61% |
|
|
|
|
|
84.04 |
4.33% |
51.74% |
38.30% |
|---|
| TGTX |
TG Therapeutics, Inc. |
3.96B |
0.59% |
|
|
|
|
|
25.59 |
1.35% |
61.48% |
40.23% |
|---|
| ILMN |
Illumina, Inc. |
21.52B |
0.59% |
|
|
|
|
|
135.12 |
3.17% |
40.22% |
13.51% |
|---|
| KRYS |
Krystal Biotech, Inc. |
5.43B |
0.56% |
|
|
|
|
|
189.04 |
3.45% |
48.06% |
30.78% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
3.34B |
0.53% |
|
|
|
|
|
54.71 |
2.00% |
82.58% |
50.24% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
5.44B |
0.52% |
|
|
|
|
|
59.07 |
2.37% |
50.52% |
24.38% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
3.12B |
0.52% |
|
|
|
|
|
48.95 |
5.39% |
70.33% |
11.19% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
6.76B |
0.51% |
|
|
|
|
|
42.85 |
1.16% |
35.48% |
32.80% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.88B |
0.51% |
|
|
|
|
|
12.01 |
0.04% |
30.96% |
9.65% |
|---|
| EXAS |
Exact Sciences Corporation |
13.11B |
0.50% |
|
|
|
|
|
70.97 |
2.54% |
49.71% |
18.06% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
12.17B |
0.50% |
|
|
|
|
|
127.61 |
2.08% |
40.23% |
2.28% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
8.00B |
0.50% |
|
|
|
|
|
75.75 |
1.41% |
32.08% |
3.26% |
|---|
| MRUS |
Merus N.V. |
3.44B |
0.50% |
|
|
|
|
|
50.48 |
2.14% |
60.84% |
17.56% |
|---|
| NUVL |
Nuvalent, Inc. |
7.40B |
0.48% |
|
|
|
|
|
106.00 |
3.28% |
43.18% |
1.27% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.56B |
0.47% |
|
|
|
|
|
71.23 |
0.13% |
29.47% |
28.07% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.84B |
0.47% |
|
|
|
|
|
92.23 |
3.24% |
45.75% |
20.16% |
|---|
| MLTX |
MoonLake Immunotherapeutics |
3.38B |
0.45% |
|
|
|
|
|
53.69 |
1.09% |
71.30% |
28.28% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
3.03B |
0.40% |
|
|
|
|
|
35.82 |
3.08% |
93.66% |
92.72% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
7.41B |
0.34% |
|
|
|
|
|
66.91 |
3.82% |
73.73% |
10.66% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.73B |
0.33% |
|
|
|
|
|
16.45 |
0.73% |
39.20% |
7.45% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.15B |
0.29% |
|
|
|
|
|
26.06 |
2.16% |
47.60% |
34.47% |
|---|
|
US Dollar |
|
0.27% |
|
|
|
|
|
|
|
|
|
|---|
| ARVN |
Arvinas, Inc. |
1.78B |
0.26% |
|
|
|
|
|
25.93 |
3.84% |
78.74% |
25.40% |
|---|
| CRSP |
CRISPR Therapeutics AG |
4.29B |
0.26% |
|
|
|
|
|
50.41 |
1.64% |
56.34% |
13.85% |
|---|